Mumbai: Haffkine Bio-Pharmaceuticals procurement cell will be seeking explanations from two pharmaceutical firms after it came to light that medicines.

THE Bureau of Internal Revenue (BIR) said 10 more medicines for cancer, high cholesterol, hypertension, and mental illness ...

The buying interest on the pharma company's counter came after it launched 'Wanbury C RED', a Liposomal Iron formulation ...

The Bureau of Internal Revenue (BIR) said 10 more medicines for cancer, high cholesterol, hypertension, and mental illness ...

THE Bureau of Internal Revenue (BIR) on Monday announced that ten additional medicines for cancer, diabetes, high cholesterol ...

TEN additional health products have been exempted from the value-added tax (VAT) and are now more accessible to the public. Based on Advisory No. 2025-0510, the ...

MORE medicines for cancer, diabetes, high cholesterol, hypertension, tuberculosis and mental diseases have been exempted from 12-percent value-added tax (VAT) by the Bureau of Internal Revenue (BIR).

In a setback for Exemed Pharmaceutical, the Subject Expert Committee (SEC) under the Central Drugs Standard Control ...

The Food and Drug Administration  has added 10 products to the list of essential medicines exempted from value-added tax  as ...

Finance Secretary Ralph Recto ordered the Bureau of Internal Revenue (BIR) to accelerate the implementation of value-added ...

The company is set to sell around 2.27% of its equity holding in Marksans Pharma, a transaction estimated at roughly ₹256.8 crore.